Bartlett & Co’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.32M | Hold |
9,625
| – | – | 0.02% | 248 |
|
|
2023
Q3 | $1.18M | Hold |
9,625
| – | – | 0.02% | 247 |
|
|
2023
Q2 | $1.22M | Sell |
9,625
-92
| -0.9% | -$12K | 0.02% | 249 |
|
|
2023
Q1 | $1.25M | Sell |
9,717
-57
| -0.6% | -$7.46K | 0.02% | 211 |
|
|
2022
Q4 | $1.28M | Sell |
9,774
-53
| -0.5% | -$6.85K | 0.03% | 211 |
|
|
2022
Q3 | $1.15M | Hold |
9,827
| – | – | 0.02% | 208 |
|
|
2022
Q2 | $1.16M | Hold |
9,827
| – | – | 0.02% | 204 |
|
|
2022
Q1 | $1.28M | Sell |
9,827
-120
| -1% | -$15.6K | 0.02% | 210 |
|
|
2021
Q4 | $1.52M | Buy |
9,947
+120
| +1% | +$18.6K | 0.03% | 200 |
|
|
2021
Q3 | $1.59M | Sell |
9,827
-600
| -6% | -$101K | 0.03% | 183 |
|
|
2021
Q2 | $1.71M | Buy |
10,427
+238
| +2% | +$36.7K | 0.03% | 182 |
|
|
2021
Q1 | $1.53M | Sell |
10,189
-200
| -2% | -$31.8K | 0.03% | 184 |
|
|
2020
Q4 | $1.57M | Hold |
10,389
| – | – | 0.03% | 180 |
|
|
2020
Q3 | $1.41M | Buy |
10,389
+120
| +1% | +$16.3K | 0.03% | 179 |
|
|
2020
Q2 | $1.4M | Sell |
10,269
-20
| -0.2% | -$2.55K | 0.04% | 173 |
|
|
2020
Q1 | $1.11M | Buy |
+10,289
| New | +$1.18M | 0.03% | 185 |
|
|
2019
Q3 | $1.02M | Sell |
10,289
-765
| -7% | -$80.1K | 0.03% | 204 |
|
|
2019
Q2 | $1.21M | Buy |
11,054
+438
| +4% | +$46.6K | 0.05% | 155 |
|
|
2019
Q1 | $1.19M | Sell |
10,616
-120
| -1% | -$13.2K | 0.05% | 158 |
|
|
2018
Q4 | $1.03M | Hold |
10,736
| – | – | 0.04% | 160 |
|
|
2018
Q3 | $1.31M | Buy |
10,736
+462
| +4% | +$54.4K | 0.05% | 151 |
|
|
2018
Q2 | $1.13M | Hold |
10,274
| – | – | 0.05% | 153 |
|
|
2018
Q1 | $1.1M | Sell |
10,274
-820
| -7% | -$90.9K | 0.05% | 153 |
|
|
2017
Q4 | $1.19M | Hold |
11,094
| – | – | 0.05% | 154 |
|
|
2017
Q3 | $1.23M | Sell |
11,094
-300
| -3% | -$32.1K | 0.05% | 149 |
|
|
2017
Q2 | $1.18M | Buy |
11,394
+300
| +3% | +$29.5K | 0.05% | 147 |
|
|
2017
Q1 | $1.08M | Sell |
11,094
-885
| -7% | -$84.7K | 0.05% | 146 |
|
|
2016
Q4 | $1.06M | Sell |
11,979
-420
| -3% | -$38.2K | 0.05% | 145 |
|
|
2016
Q3 | $1.2M | Sell |
12,399
-165
| -1% | -$15.7K | 0.06% | 139 |
|
|
2016
Q2 | $1.08M | Sell |
12,564
-51
| -0.4% | -$4.58K | 0.05% | 144 |
|
|
2016
Q1 | $1.1M | Hold |
12,615
| – | – | 0.06% | 142 |
|
|
2015
Q4 | $1.42M | Sell |
12,615
-300
| -2% | -$32.6K | 0.07% | 126 |
|
|
2015
Q3 | $1.31M | Sell |
12,915
-1,800
| -12% | -$216K | 0.07% | 128 |
|
|
2015
Q2 | $1.81M | Hold |
14,715
| – | – | 0.09% | 115 |
|
|
2015
Q1 | $1.69M | Sell |
14,715
-3,765
| -20% | -$415K | 0.08% | 118 |
|
|
2014
Q4 | $1.87M | Sell |
18,480
-4,905
| -21% | -$477K | 0.09% | 116 |
|
|
2014
Q3 | $2.13M | Buy |
23,385
+12,435
| +114% | +$1.09M | 0.1% | 104 |
|
|
2014
Q2 | $938K | Hold |
10,950
| – | – | 0.05% | 154 |
|
|
2014
Q1 | $863K | Hold |
10,950
| – | – | 0.04% | 151 |
|
|
2013
Q4 | $829K | Buy |
10,950
+300
| +3% | +$21.3K | 0.04% | 155 |
|
|
2013
Q3 | $744K | Hold |
10,650
| – | – | 0.04% | 159 |
|
|
2013
Q2 | $617K | Buy |
+10,650
| New | +$616K | 0.03% | 163 |
|
Other funds holding IBB
CB
Bartlett & Co's IBB Position: Q4 2023 in Review
Bartlett & Co held its iShares Biotechnology ETF (IBB) position steady in Q4 2023 at 9,625 shares worth $1.32M. The position accounts for 0.02% of the portfolio, ranked #248.
Bartlett & Co first reported a position in IBB in Q2 2013 and has held it in 42 quarters since. The position peaked at $2.13M in Q3 2014. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.
- Bartlett & Co held 9,625 shares of iShares Biotechnology ETF worth $1.32M as of Q4 2023.
- Bartlett & Co left its iShares Biotechnology ETF share count unchanged in Q4 2023.
- iShares Biotechnology ETF made up 0.02% of Bartlett & Co's portfolio in Q4 2023, its #248 holding.
- Bartlett & Co first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 42 quarters since.
- Bartlett & Co's iShares Biotechnology ETF position peaked at $2.13M in Q3 2014.
- 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.